Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > Living in a pathogen paradise...
View:
Post by prophetoffactz on Dec 02, 2023 12:17pm

Living in a pathogen paradise...

We’re in our *3rd* post-lockdown viral respiratory season and admissions for viral resp illness+pneumonia are 6 standard deviations above the historical average. I do not understand how so many reasonable people haven’t figured out that the “immunity debt” scapegoat is disinfo.

It’s not the lockdowns, it’s the covid. Covid damages immune systems. Catching covid makes people more susceptible to catching other infections. Immunity theft, not immunity debt. A thread of evidence:

This study found that the risk of RSV infection needing medical attention was 40% higher in kids that had covid vs those that didn’t. Both in 2021 and 2022. Yes they checked twice.

This study shows that the terrible 2022 RSV epidemic was not as simple as a “catch up” year. RSV was already back in 2021. The 2022 surge was driven by *more severe cases*. What happened between 2021 and 2022? Mass infection of children with omicron. And subsequent immune damage.

“the large buildup of COVID19-infected children and the potential long-term adverse effects of COVID-19 on the immune and respiratory systems may have contributed to the 2022 winter surge of severe RSV diseases that was not seen in 2021.” 2021: immunity debt 2022: immunity theft

Now let’s talk about cascading effects. This is a really interesting study that highlights the role of RSV as a cofactor in invasive pneumococcal disease.

There is no pneumococcal immunity debt because people carry it around asymptomatically so it’s always around. And here they showed that while invasive disease dropped during the lockdowns, pneumococcal carriage rates were not significantly reduced.

But when RSV and influenza came back, so did invasive pneumococcal disease. So S. pneumoniae piggybacks on RSV/influenza to infect children. So the cascading effect here is that covid increases susceptibility to RSV which increases susceptibility to this invasive infection.

More covid = more RSV = more invasive pneumococcal infections.

Moving on. This study found more cases of shingles (a virus that can reactivate when your immune system is down) across all ages in those that had covid. Worse, the risk of severe shingles (disseminated zoster) was 2.8x higher for the post covid group.

You see what the authors do here? They go over the already known biologic effects of covid (lower T cell counts persisting after recovery from the acute phase) and do an easy little 1+1=2. The math is mathing. No need to pretend this is a big mystery.

Another cascading effect here is strokes. It’s already well established that covid infections significantly increase your risk of stroke for months. The shingles virus is vasculopathic and also increases your risk of stroke post infection.

Strep infections are surging yet again. What does the data say? Oh, it says it’s covid. “The hazard ratio for streptococcal tonsillitis was elevated in SARS2 positive patients from 4 to 8 months after diagnosis, peaking at 6 months (hazard ratio 1.27).”

It’s not the lockdowns. It’s the covid. And honestly any expert that’s talking about the surges in infections we’re seeing without saying anything about covid immune damage in December 2023, with all this published data, is either woefully uninformed or outright dishonest.

Someone did study it. They found a 7x increased incidence of tuberculosis post-covid pneumonia and a 3.85x increased risk of TB ipost-symptomatic covid without pneumonia. This graph is pretty telling. It’s not the lockdowns. It’s the covid.

We’ve known covid increases your risk of bacterial infections for a long time. Long before the immunity debt fairy tale went mainstream. In this 2021 study, the 6 month hazard ratio of bacterial infections post covid was 1.43. (supplementary table 5)
Be the first to comment on this post